Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade BgagVaccines in Healthy Adults-Reference-Cited by-同舟云学术

Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade BgagVaccines in Healthy Adults

Published:2009-01 Issue:1 Volume:25 Page:103-114
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Harro Clayton D.¹,Robertson Michael N.²,Lally Michelle A.³,O'Neill Lori D.²,Edupuganti Srilatha⁴,Goepfert Paul A.⁵,Mulligan Mark J.⁴,Priddy Frances H.⁴,Dubey Sheri A.²,Kierstead Lisa S.²,Sun Xiao²,Casimiro Danilo R.²,DiNubile Mark J.²,Shiver John W.²,Leavitt Randi Y.²,Mehrotra Devan V.²

Affiliation:

1. Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21205.

2. Merck Research Laboratories, West Point, Pennsylvania 19486.

3. Warren Alpert Medical School of Brown University, Providence, Rhode Island 02912.

4. Emory University, Atlanta, Georgia 30030.

5. University of Alabama, Birmingham, Alabama 35294.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2008.0212